Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
INTRODUCTION: The biomarker-based amyloid/ tau/ neurodegeneration (A/T/N) framework has become a popular staging method for Alzheimer's disease (AD) research. Previous studies use the framework either as a rule-based or data-driven approach but typically sacrifice either adaptivity or interpretability. METHODS: We present an interpretable, hybrid method, called Neurosymodal Data Fusion, for predic...
Introduction: Cerebral amyloid angiopathy (CAA) is characterized by amyloid-beta deposition in cortical and leptomeningeal vessels and associated with cognitive impairment and hemorrhage. Current neuropathological assessments rely on semiquantitative grading and lack vessel-level resolution and scalability. Existing computational pathology approaches also fail to capture individual vessel morpholo...
Scaling laws describe how model performance improves as the amount of training data increases, and recent theories such as the zeta law suggest that s...
People with Down syndrome have higher age-specific mortality rates compared to the general population as well as peers with other intellectual and dev...
Deep learning classifiers applied to structural MRI (sMRI) have achieved high performance in detecting Alzheimer's Disease (AD), yet systematic invest...
Background. Predicting conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) is central to trial enrichment and care planning, y...
Real-time EEG classification on edge devices is bottlenecked by the floating-point arithmetic of conventional neural networks. We investigated Differe...
A hallmark of neurodegenerative diseases such as Alzheimer's and Parkinson's is the aberrant aggregation of proteins into amyloid fibrils, and small m...
INTRODUCTION: Brain age gap (BAG) is the difference between a person's chronological age and the age predicted from the structural appearance of their...
Mild Cognitive Impairment is a critical early stage of cognitive decline that frequently precedes Alzheimer's disease, yet its automated detection fro...
Accurately attributing causes of death is vital for global health, yet fewer than 5% of deaths in resource-constrained regions are medically certified...
Methods INCA is a prospective, single-center cohort study with nationwide recruitment. Participation is open to adult patients and informal caregivers...
Background & Methods: The multifaceted physical nature of heritable cognitive impairment in dementia presents significant challenges for traditional l...
Dementia is a progressive neurological condition characterized by cognitive decline and structural brain changes that evolve. Longitudinal modeling of...
The non-amyloid {beta} component (NAC) domain of alpha synuclein (Syn) drives Syn aggregation in Parkinson disease, yet as an intrinsically disordered...
Accurate diagnostic classification and disease-severity prediction for Alzheimer's disease are hampered by the incompleteness and heterogeneity of rea...
Background: Antimicrobial resistance poses a major threat to global public health. Large language models (LLMs) offer new possibilities for optimizing...
Emerging as a significant global health challenge, Alzheimer's Disease (AD) is a progressive neurodegenerative disorder that causes memory loss and co...
Objectives: Explore the perspectives of primary caregivers towards pediatric tissue-based research participation. Design: Cross-sectional. Setting: Tw...
Accurate diagnostic classification and disease-severity prediction for Alzheimer's disease are hampered by the incompleteness and heterogeneity of rea...